Yixie Innovation is the key to a high-end market

      China Pharmaceutical Network Market Analysis has been a huge economic burden on imported products bring high Yixie become irrational increase of medical costs and patients' medical treatment is difficult and expensive, "an important factor. China has made some achievements in the low-end medical equipment production and innovation, so now their eyes locked on the high-end medical equipment products. At the same time, speed up the review and approval of medical devices for the opening of some companies 'green channel', so that the independent innovative products to market quickly, to keep up with the pace of replacement medical device market.

      2016 spring still in the pipeline, the medical device industry has ushered in ahead of "spring." Recently, Premier Li Keqiang chaired a State Council executive meeting, the deployment of the pharmaceutical industry to promote innovation and upgrading. Referring to the medical device innovation and upgrading, the Prime Minister stressed the need to strengthen the high-end medical equipment research and innovation; benchmarking the international advanced level, the implementation of actions to improve the standards of medical devices; the urgent need to accelerate the clinical review and approval of medical products.

      The good news for the domestic innovative medical device companies a "booster." China Medical Equipment Association, Zhao Zilin said in recent years, along with the country's growing demand for medical services, the state introduced a number of policies and measures, and to increase capital investment, promote domestic medical equipment technology, development and application of new products. "China is the world's second-largest medical device market, the utilization of high-end medical equipment. The Prime Minister also mentioned the need to improve the overall level of production of medical equipment research and development, accelerate review and approval, which means to accelerate the integration of the whole industry chain."

Locking high-end medical equipment

        2015, "China Medical Equipment" magazine has done a survey, the results show that in CT, MRI, nuclear medicine, angiography and other types of large medical equipment in the industry as "GPS" GE Philips, Siemens three multinational market share of over 80%.

       Huge economic burden caused by high import products become unreasonable medical expenses and patient growth "difficult and expensive" is an important factor. In addition, the president of the Chinese Medical Device Industry Association Jiang Feng told reporters: "China has made in the low-end medical equipment production and innovation of certain results, so now their eyes locked on the high-end medical equipment products at the same time, speed up medical device. review and approval, as some companies open 'green channel', so that the independent innovative products to market quickly, to keep up with the pace of replacement medical device market. "

      According to statistics, in 2015 the State Administration of Medical Device Evaluation Center publicity of eight innovative medical device approval process to apply for special review, a total of 29 innovative products to enter the special approval "green channel", involves genetic testing, vascular stents, tissue engineering products surgical robot positioning systems.

Innovation, lack of motivation

      Under the "public entrepreneurship Peoples innovation" in the context of national innovation increasingly attach importance to the medical device industry, but in the eyes of Jiang Feng, the degree of attention is still not enough, "We've done some in the technology, funding, public opinion work, but to support product innovation environment is not fully formed tilt policy efforts for product registration, procurement, deployment, diffusion is still not enough, not enough to stimulate business innovation. "

     Research and development in the production of medical equipment, domestic enterprises common practice: for foreign-funded enterprises in a certain kind of value-added high domestic market size of existing or potential large market for imitation products, after the completion of product sales and achieved certain foundation and further to expand to other product areas and diversify the mode copy. And this approach to a certain extent, dealt a blow to the enthusiasm of enterprises, "Many Chinese companies want to earn quick money, earn quick money approach is generic products of others. Blind imitation patent protection leads to non-existent, to suppress a number of innovative enterprises, and ultimately so that the enthusiasm of enterprises is not enough. "Jiang Feng said.

      He also voiced another concern: "products need talent, high-end products need high-tech talent to take the watch, for example, why some Swiss watches price up to a million, while China's production of watches only million. yuan price level hovering? because we lack the talent to master the sophisticated technology. the training of personnel is a long process, because a large number of foreign companies can not produce new technology medical device products in China, with foreign standards can not technically, but also We will not be able to cultivate first-class innovative qualified personnel. "

The low-end products & high-end products

     The good news is, with the support of innovation environment matures, domestic medical device companies are also quite a number of innovations, a large number of independent intellectual property rights, high-performance, low-cost and high-end medical products to the market, to meet the needs of our health care institution-building and clinics, some of which products have been able to replace imported.

     There are some companies pay more attention to cooperation with medical institutions, as well as docking with foreign R & D institutions, combining the strengths in research and development, standing on the shoulders of giants engage in innovation. "In the past, medical device companies relatively closed, our attitude now more open and willing to receive advanced concepts and practices of others so that we can start relatively high, although China's medical device companies mostly aged under 30, but if the initial high, rapid progress, will one day catch up with foreign level. "Zhao Zilin said.

      Jiang Feng suggested that companies should focus focus on product innovation, the first not to blindly pursue innovative business models. "Business model innovation is based on product innovation presented without product innovation, there is no so-called business model innovation. Innovative products may require new business models to promote, at this time are not contradictory, but if juggle in the area of sales and is not conducive to product innovation. Therefore, the current medical device industry does not promote business model innovation, we are to step by step starting from the low-end medical equipment product innovation, high-end medical equipment to enter. "Jiang Feng said.

High-tech products will become the hot spot

      Medical Device Technology for innovation, Jiang Feng said he was optimistic about the following aspects: small and medium surgical products and supplies, minimally invasive surgical techniques; clinical in vitro diagnostic machines and reagents; home medical equipment, medical products wisdom; biomaterials; high-end consumables ,Implants.

      In the 2015 annual National Science and Technology Awards Conference, Bomun technology with "China Innovation Theory Humans difficult healing and prevention of new features and key measures of the wound occurred," National Science and Technology Progress Award gains, and has become the first medical device industry the award-winning enterprise. Meanwhile, the "minimally invasive implantable medical devices and key technology and industry platform" and other five medical device-related technology, three medical device companies won the National Science and Technology Progress Award.

     "Conform to the precise medical needs, future trends in the medical device industry is increasingly clear that the core of high-tech products will become the industry focus of attention and investment." Zhao Zilin told reporters, just grab widely used in clinical, patient cost impact these two large companies is not difficult to find innovative breakthrough.

High quality is always the pursuit

      If the medical device companies want to make a breakthrough in high-end medical equipment, Jiang Feng said: "Enterprises must first understand what they need to do is to earn quick money to do innovation or innovation if it determines to be done, both to learn and cooperate. attention to product quality. "

       For a long time, China's medical equipment manufacturing enterprises are mostly small-scale and scattered layout. These small businesses, not just low-tech production, safety and effectiveness of its production process and quality control is a big problem. Jiang Feng believes that enterprises should pay attention to cooperation, "foreign medical device market has entered a virtuous circle, small businesses do innovation, product, big companies do to improve, industry, large enterprises to small businesses living space, orderly cooperation, a few years after the big mergers and acquisitions of small businesses, while our national products in the global market share of less than 5%, but each product has dozens of enterprises in production, features and performance parameters are not much different, every business is going it alone, disorderly competition. "Jiang Feng said.

       Jiang Feng said Chinese enterprises lack of attention to product quality, the same kind of high quality products, produced in Germany and Japan, the production of low-quality Chinese production, because Chinese enterprises do not pay attention to quality, processes and materials. He had identical views with Jiang Feng, "High-quality products in order to obtain approval, the product again for Chinese patients, the product can be achieved constantly upgrading, companies may be able to develop further." Said Jiang Feng.